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Summary 
CD8 is a cell surface glycoprotein on major histocompatibility complex class I-restricted T cells. 
Thymocytes and most peripheral T  cells express  CD8 as heterodimers of CD8ot  and CD8/3. 
The intestinal intraepithelial lymphocytes (IEL),  which have been suggested to be generated 
extrathymically, express CD8 predominantly as homodimers of CD8ot. We have generated CD8/3 
gene-targeted mice. CD8tx + T cell population in the thymus and in most peripheral lymphoid 
organs was reduced to 20-30% of that in wild-type littermates. CD8ot expression on thymocytes 
and peripheral T cells also decreased to 44 and 53% of the normal levels, respectively.  In contrast, 
neither the population size nor the CD8~ expression level of CD8ot § IEL was reduced. This 
finding indicates that CD8~ is important only for thymic-derived CD8 + T  cells. The lack of 
CD8B reduces but does not completely abolish thymic maturation of CD8 + T cells. Our result 
also reveals the role of CD8/3 in regulating CDSc~ expression on thymic derived T cells. Peripheral 
T  cells in these mice were efficient in cytotoxic activity against lymphocytic choriomeningitis 
virus and vesicular stomatitis virus, suggesting that CD8/3 is not essential for the effector function 
of CD8 + T  cells. 
C 
D8 is expressed on MHC class 1-restricted T  cells as 
a disulfide-linked heterodimer of c~ and/3 subunits (1-3). 
The exception are the intestinal intraepithelial lymphocytes 
(IEL)  1 that express  CD8 predominantly as homodimers of 
CDSol (4). Cell surface expression of CD8/3 requires the coup- 
ling with CD8ot as heterodimers, whereas CD8ot can be ex- 
pressed on the cell surface as homodimers (5-8).  CD8 has 
been suggested to have dual functions. It serves as an adhe- 
sion molecule to enhance the affinity of T cells to their target 
cells (9-11).  It is also a coreceptor of TCR and participates 
in TCR signaling (10,  12-17).  The coreceptor function of 
CD8 requires the coengagement of CD8 and TCR to the 
same MHC class I molecule (12, 13, 15-17),  and the associa- 
tion of CD8 with protein tyrosine kinase p56 lc~ (10, 11, 14). 
The extracellular portion of CD8ot binds to the or3 nonpoly- 
morphic domain of MHC class I molecules (12, 13, 18-20), 
and the cytoplasmic portion of CD8ol is associated with the 
protein tyrosine kinase p561ok (21). 
1 Abbreviations used in  this paper: ES cells, embryonic stem cells; IEL, 
intraepithelial  lymphocytes;  I-CMV, lymphocytic  choriomeningitis  virus; 
pfu, plaque-forming  unit; VSV, vesicular stomatitis virus. 
CD8 is crucial for thymic maturation of cytotoxic T cells 
(22-24).  Mice bearing a null mutation at the CD8ot gene 
by gene targeting lack MHC class I-restricted T  cells and 
are defective in cytotoxic effector function (24).  T  cell re- 
sponse can be synergized by transfected CDSo~ (9,  10,  13, 
14, 25, 26). However, CDSot~ heterodimers have been reported 
to be more effective than CD8cr homodimers in enhancing 
T  cell response (27,  28).  The role of CDS~ in T  cell on- 
togeny and function is still largely unknown. A regulatory 
role of CD8/3 in altering the structure of CD8 complex upon 
T  cell activation has been suggested (29).  A recent report 
on mice chimerized with CD8~ gene-targeted embryonic stem 
(ES) cells suggested that CD8/3 is necessary for thymic matu- 
ration of CD8 + T cells (30). We have simultaneously gener- 
ated CD8B  gene-targeted mice. Our study showed that a 
significant  peripheral  CD8 +  T  cell  population  was  still 
present in these mice. We also compared the CD8 § T  ceils 
in the peripheral lymphoid organs and in the intestinal epi- 
thelium. The result demonstrates that CD8~ is important 
only for CD8 + T  cells from the thymus, but not for IEL. 
We further examined the cytotoxic effector function of pe- 
ripheral T cells against lymphocytic choriomeningitis virus 
(LCMV) and vesicular stomatitis virus (VSV)  infection. 
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Disruption of the CD8/3 Gene in Mice by Homologous Recombina- 
tion.  A 2.5-kb mouse genomic DNA fragment covering the first 
exon of the CD83 gene,  0.4 kb of the 5' flanking region and 2 
kb of the intron region was used in the gene-targeting construct 
(Fig. 1 A). The neomycin resistance genepMClneopolA (Stratagene, 
La Jolla,  CA) was inserted into the NcoI site within exon i  of the 
gene. The gene-targeting construct was electroporated into D3 ES 
cells as described  previously (24).  Transfected  cells were selected 
by G418 and the targeted gene was detected by PCR. using primers 
specific for the neomycin resistance gene and the CD83 gene. The 
targeted CD83 gene in cells was eventually confirmed by genomic 
hybridization. ES cells with the targeted CD83 gene were injected 
into blastocysts  to generate chimeric mice. Mice heterozygous for 
the targeted CD83 gene (CD83  +/-  mice) were obtained from 
chimeric mice by germline transmission.  Mice homozygous (-/-) 
for the disrupted CD83 gene were obtained by crossbreeding  of 
CDSB  +/-  mice. 
Flow Cytometric  Analysis of  Lymphocytes.  Single cell suspensions 
from thymus, spleen, and lymph nodes of 6-8-wk-old mice were 
prepared.  IEL were purified  from the intestine according to the 
method described by van der Heijden and Stock (31). 106 cells were 
stained with mAb for 30 rain at 4~  in 100 #l of PBS containing 
2% FCS and 0.1% sodium azide. Cells were then washed and ana- 
lyzed for single-,  double-, and triple-color flow cytometry on a 
FACScan  |  (Becton Dickinson & Co., Mountain View, CA). mAb 
used were specific for CD8o~, CD8/3, CD4, and CD3 (PharMingen, 
San Diego, CA). Anti-Thy-1  and anti-B cell specific CD45 mAb 
(PharMingen) were used for detecting T and B cells, respectively. 
LCMVinduced Footpad Swelling Reaction.  Mice were infected 
with 500 plaque forming units (pfu) of LCMV-Armstrong (32) by 
intradermal injection into hind footpads.  Footpad thickness  was 
measured  daily with a spring-loaded caliper.  Footpad swelling is 
calculated as (actual thickness  -  thickness before infection)/(thick- 
hess before infection). 
Primary Ex Vivo Cytotoxicity against LCMV Infection.  Mice were 
immunized by intradermal injection of 30 #1 LCMV-Armstrong 
(500 pfu). On day 8, spleen cells were tested  for LCMV-specific 
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Figure  1.  Disruption of  the CD8/3  gene by ho- 
mologous  recombination. (A) The 5' region of the 
mouse CD83 gene within  the 2.5-kb HindlIl- 
digested DNA fragment was used in the gene- 
targeting construct. The neomycin  resistance gene 
was inserted in reverse orientation into the NcoI 
site within exon I of the CD83 gene. The restric- 
tion maps of the CD83 gene before and after ho- 
mologous recombination are shown. The 5' and 
3' probes, as well as the neo probe used in genomic 
hybridization are shown. Solid squares, exons; E, 
EcoRl; H,  Hindlll;  B, BamHI; N,  Ncol.  (B) 
CD83 +/+, +/-, and -/-  mice  were confirmed 
by genomic hybridization. The intact CD83 gene 
after EcoRI digestion was hybridized  by the 5' and 
3' probe as an 11.5-kb DNA fragment, whereas 
the disrupted CD83 gene was split into two 6.5- 
kb DNA fragments. The disrupted CD83 gene 
was also identified by the neo probe as a 3.5-kb 
DNA fragment after HindlII digestion. 
CD83 Is Needed for Maturation but Not Effector Function of CD8 + T  Cells cytotoxicity in a 4-h 51Cr release assay. Target ceils were EL4 cells 
(H-2  b)  that  had  been  incubated with  or  without  the  relevant 
MHC class 1-binding LCMV glycoprotein peptide (amino acid 
residues 33-42, 50 mM) for 1 h at 37~  (33, 34). 51Cr release was 
measured in duplicate and mean values are shown. Spontaneous 
SlCr release was <20% for all target cells. Specific 51Cr release was 
calculated  as  (measured  51Cr release  -  spontaneous  51Cr re- 
lease)/(total 5tCr release  -  spontaneous SlCr release). 
Primary Ex Vivo Cytotoxicity against VSV Infection.  Mice were 
immunized intravenously with VSV (2  ￿  106 pfu serotype Indiana 
in 200/xl) on day 0. On day 6, spleen cells were tested for cytotox- 
icity in a 4-h 51Cr release assay. The EL-4 target cells were either 
uninfected or infected with VSV (15 pfu/cell) for 3 h  at 37~ 
51Cr release was measured in duplicate and mean values are shown. 
Spontaneous 51Cr release was <20%  for all target cells. Specific 
51Cr release was calculated  as described  above. 
LCMV-specific Cytotoxicity after ln Vitro Restimulation.  Mice were 
immunized with LCMV-Armstrong as described in the above sec- 
tion. On day 8, spleen cells were restimulated in vitro with irradi- 
ated peritoneal macrophages that had been infected with LCMV, 
as described in detail previously (35). Spleen cells were harvested 
after 5 d and tested for cytotoxicity on LCMV glycoprotein pep- 
tide-labeled EL-4 target cells as described above. Spontaneous 51Cr 
release was <22%  for all target cells studied. 
VSV-specific Cytotoxicity after In Vitro Restimulation.  Mice were 
immunized intravenously with VSV as described above. On day 
6, spleen cells were restimulated with irradiated syngeneic C57BL/6 
spleen cells that had been cultured with UV inactivated VSV (15 
pfu/ceU) for 1 h at 37~  3  x  106 responder spleen cells were re- 
stimulated with 2  x  106 stimulator cells in 24-well plates.  After 
5 d  of culture, spleen cells were tested for cytotoxicity on VSV- 
infected EL-4 target cells as described above. Spontaneous 51Cr re- 
lease was <16%  for all target cells studied. 
Results 
Generation of the CD8fl Gene-targeted Mice.  To understand 
the role of the CD8B in T  cell ontogeny and function, we 
generated mice with the CD8B gene disrupted by homolo- 
gous recombination. The CD8~ gene was mutated in exon 
1 by an insertion of the neomycin resistance gene (Fig. 1 A). 
The site of insertion is 7 nucleotides downstream from the 
translation start site, which would abolish translation of the 
CD8B protein. Mice chimerized with CDS~/gene-targeted 
ES cells were generated from embryo injection. CDSB  +/- 
mice were obtained from germline transmission of chimeric 
mice and CD8/3  -/-  mice were from cross-breeding of CD8B 
+/-  mice.  Disruption  of the  CD8B  gene  in  mice  was 
confirmed by genomic Southern hybridization (Fig. 1 B). The 
CD8/~  -/-  mice were fertile and appeared to be healthy. 
Cell numbers recovered from thymi, lymph nodes,  spleens, 
and intestinal epithelia of the CD8B  -/-  mice were similar 
to those from wild-type littermates (Table 1). The percen- 
tages of the T  cell and B cell subsets in different peripheral 
lymphoid organs of CD8B  +/-  and  -/-  mice were within 
normal ranges  (Table 2). 
Reduction  in Population Size  and  in  CD8cr  Expression  of 
Thymic-derived CD8 + T  Cells.  CD8/~ was not detected on 
peripheral T cells or thymocytes from CDS~/-/-  mice (Figs. 
2, 3, and 4). However, CD8ot + T  cells were present in the 
peripheral lymphoid organs of CD8/3  -/-  mice (Figs.  2, 
3,  and Table 3).  CD8ot + T  cells in CD8B  -/-  mice had 
a normal level of TCR expression (data not shown), hut the 
population size was smaller than that in wild-type littermates. 
In lymph nodes,  CDSc~ +  T  cells were reduced to 30%  of 
Table  1.  Cell Numbers Recovered  from Different Lymphoid Organs of the CDSfl  +/+,  +/-,  and  -/-  mice. 
Mouse  Lymph  Intestinal 
genotype  Thymus  nodes  Spleen  IEL 
CD8/3  +/+  10.0  ￿  107  0.9  ￿  107  4.5  ￿  107  1.2  ￿  106 
CD8~  +/-  7.1  ￿  107  6.0  x  107  5.4  ￿  107  3.0  ￿  106 
CD8~  -/-  11.5  ￿  107  1.0  ￿  107  10.2  ￿  107  1.4  x  106 
Table  2.  The Percentages of B Cell and T  Cell Populations in Lymphocytes from  Different Lymphoid Organs of the CD8fl  +/+, 
+/-,  and  -/-  mice 
Lymph nodes  Spleen  Blood 
Mouse 
genotype  B cell  T  cell  B cell  T  cell  B cell  T  cell 
CD8~  + / +  26%  74%  49%  51%  27%  73% 
CD8/~  +/-  22%  78%  54%  46%  35%  65% 
CD8/3  -/-  24%  76%  58%  42%  39%  61% 
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Figure 2.  Decreased CD8o~ expression on CD8 + T 
cells from  CD8~8 gene-targeted  mice. Histograms  of 
CDSB, CD8c~  expression on thymocytes, and lymph node 
cells from CD8B +/+, +/-, -/-  mice are shown. Mean 
values of CD8 stainings are shown under the peaks. Mesen- 
teric lymph node cells were stained with mAb against 
CD8~ and CD8~8  as described in Materials and Methods. 
Samples were analyzed using the FACScan  |  program. Ma- 
chine settings for acquisition of thymus and lymph node 
samples were different. 
that in wild-type mice (Fig. 3). Ratios of CD4 + to CD8o~  + 
T cells in the peripheral  lymphoid organs of CD83  -/- 
mice were about 10:1 in repeated experiments,  as opposed 
to the ratio of about 1.6:1 in wild-type littermates  (Fig. 3, 
Table 3). Immature thymocytes in CD83  -/-  mice were 
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CD4 + CDSc~  + double positive and were normal in popu- 
lation size and in CD3 expression (Fig. 4). Consistent with 
the observation in the periphery, the subset of CDSc~  + ma- 
ture thymocytes in CD83  -/-  mice was reduced to 20% 
of that in wild-type mice (Fig. 4). In contrast,  the CDSo~  + 
IEL population in CD83  -/-  mice was comparable with 
that in wild-type mice (Fig. 5). The IEL cell number har- 
vested from the intestinal epithelia of CD83  -/-  mice was 
also in a normal range (Table 1). 
A significant reduction of CD8cr surface expression was 
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Figure 3.  Decreased CD8a + T  cell population in lymph nodes of 
CDS~/gene-targeted mice. Mesenteric lymph node cells from CD83 +/+, 
+/-, and  -/-  mice were double stained with mAb specific for CD4, 
CD8cr  and CD83 and analyzed by flow cytometry. 
Figure 4.  Decreased thymic ontogeny of CD8a + T  cells in CD83 
gene-targeted mice. Thymocytes from CD83 +/+, +/-, and -/-  mice 
were triple stained with mAb specific  for CD3, CD4, CDSol, and CDS3 
and analyzed by flow cytometry. 
962  CD8~ Is Needed for Maturation but Not Effector Function of CD8 § T  Cells Table  3.  The Ratio  of CD4 §  T  Cell  to CD8 §  T  Cell Subsets in Different Lymphoid Organs of the CD8/]  +/+,  +/-, 
and  -/-  Mice 
Mouse  Lymph 
genotype  Thymus  nodes  Spleen  Blood 
CD8B  + / +  3.7:1  1.6:1  1.8:1  1.1:1 
CD8~  +/-  3.3:1  1.7:1  2.6:1  3.6:1 
CD8/3  -/-  14:1  8.7:1  9.5:1  11.5:1 
found on peripheral T  cells from CD8B  -/-  mice (53% 
of the level in wild-type control mice) (Fig. 2). CD8a ex- 
pression levels on immature thymocytes from CD8~-/-  mice 
were also low (44%  of normal levels) and spanned a wide 
range (Fig. 4). Low CD8cr expression was particularly  ob- 
vious for early stage thymocytes which display low levels of 
CD3 expression. In contrast, CD8c~ expression levels on IEL 
from CDSB  -/-  mice were unchanged (Fig. 5). 
In conclusion,  the absence of CD8/3 only affects thymic 
derived T cells but has no impact on IEL. CD8B is needed 
for optimal  CD8ot expression and e~cient thymic matura- 
tion of CD8 § T  cells. 
CD8 +  T  Cells  without  CD8fl  Are  Efficient  in  Cytotoxic 
Effector Function against In Vivo Viral Infection.  CD8~  -/- 
mice provide a well-defined animal model for studying the 
in vivo immune response and effector function of the CD8 + 
T  cells that lack CD8~.  Cytotoxic T  cell responses were 
studied in CD8/3 -/-  mice after infection with LCMV and 
VSV. LCMV-specific CTL function in vivo was assessed by 
monitoring footpad swelling after intradermal injection  of 
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Figure  5.  Normal  CD8tx + 
IEL in CD8/3 gene-targeted mice. 
Intestinal  IEL cells were purified 
from CD8~ +/+, +/-, and -/- 
mice as described in Methods and 
Materials. Cells were stained with 
mAb  specific for  CDSa  and 
CD83  and  analyzed  by  flow 
cytometry. 
LCMV. Due to extensive local virus replication,  the T cell 
response  against  LCMV  causes an  immunopathological 
swelling reaction of the footpad.  The early phase  of the 
swelling reaction (starting on day 8) is mediated exclusively 
by CD8 + cytotoxic T cells (36-38).  This swelling reaction 
was normal in CD83  -/-  mice (Fig. 6 A), demonstrating 
that an e~cient in vivo cytotoxic T cell activity can be trig- 
gered in these mice. 
Primary ex vivo cytotoxic T cell function was assessed  with 
SlCr release assays. After 8 d of LCMV infection in CD8~ 
-/-  mice, peripheral T cells showed a virus-specific cyto- 
toxicity comparable to that in wild-type controls (Fig. 6 B). 
Similarly, ef~dent VSV-specific  cytotoxic activity was observed 
in  CD8/3  -/-  mice after  VSV  infection  (Fig.  6  C).  The 
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Figure  6.  Normal effector function of cytotoxic T cells in CD83 gene- 
targeted mice. (A) Mice were infected with I.CMV locally into hind footpads 
as described in Materials and Methods.  Footpad swelling is calculated as 
(actual thickness  -  thickness  before infection)/(thickness  before infec- 
tion). Open triangles, CD83  -/-  mice; solid triangles, CD8/3  +/+  mice. 
Each curve shows the swelling of the hind footpad of one mouse. (/3) Spleen 
cells from mice immunized with LCMV were tested for cytotoxicity on 
EL-4 (H-2  b) target cells that were labeled with the relevant MHC class 
I-binding LCMV  glycoprotein  peptide,  as  described  in  Materials  and 
Methods.  Open triangles, CD8~  -/-  mice; solid triangles, CD8/3  +/+ 
mice; solid circles, unprimed C57BL/6 (H-2  b) control mice. Nonspecific 
lysis on EL-4 target  cells without  the viral peptide  was  <10%  for the 
different effector cells. (C) Mice were intravenously  infected with VSV 
and spleen cells were tested for cytotoxicity on VSV-infected Eb4 target 
cells, as described in Materials and Methods.  Open triangles, CD83  -/- 
mice; solid triangles, CD83  +/+  mice; solid circles, unprimed C57BL/6 
(H-2 b) control mice. Nonspecific lysis on uninfected EL-4 target cells was 
<4% for the different effector cells. For both B and C, each curve represents 
values taken  from one mouse.  51Cr release was measured  in duplicate, 
mean values are shown (SD <13% for all values). Specific slCr release was 
calculated as (measured  slCr release  -  spontaneous  SlCr release)/(total 
51Cr release  -  spontaneous  51Cr release). 
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Figure  7.  Efficient  effector function of cytotoxic T cells in CD8/~ 
gene-targeted  mice. (.4) Spleen cells from  mice  infected  with LCMV  were 
restimulated  in vitro  with LCMV-infected  irradiated  peritoneal  macrophages, 
as described in Materials and Methods. Cytotoxicity  of spleen cells on 
LCMV glycoprotein  peptide labeled EL-4 target cells are shown. Open 
triangles, CDS/~ -/- mice;  solid triangles, CDSB +/+ mice;  solid circles, 
unprimed C57BL/6 control mice. Spontaneous slCr release was <22% 
for all targets shown. (B) Spleen cells from VSV-infected  mice were re- 
stimulated  with irradiated  syngeneic  C57BL/6 spleen cells that had been 
cultured  with UV-inactivated  VSV, as described  in Methods  and Materials. 
Cytotoxicity  of spleen cells on VSV-infected  EL-4 target cells  was studied. 
Open triangles, CD83 -/-  mice; solid triangles, CD8/3 +/+ mice; solid 
circles, unprimed C57BL/6 control mice. Spontaneous SlCr release was 
<16% for all targets shown. 
demonstration of  primary ex vivo cytotoxicity  in CD83 -/- 
mice suggests that an in vivo proliferation of the CD8 + T 
cells must have occurred, because  the frequency of antigen 
specific CTL must be in the range of 10-2 to allow detect- 
able primary ex vivo cytotoxicity (35,  39). 
Although primary ex vivo cytotoxicity  against LCMV and 
VSV in the CD83  -/-  mice was observed, a slight reduc- 
tion was noticed when compared with those in wild-type 
mice. The question as to whether this reduction resulted from 
a limited number of CD8 § T  cells or a decreased  effector 
function of the CD8 + T cells is clarified by performing 51Cr 
release assays after in vitro restimulation. The difference in 
numbers of effector cells is evened  out by further in vitro 
proliferation of effector cells during the restimulation. As 
demonstrated in both LCMV- and VSV-specific responses, 
the cytotoxic activities of the restimulated effector cells from 
CD83  -/-  mice were as effective as those from wild-type 
littermate controls (Fig.  7). 
In conclusion, peripheral CD8 + T  cells in CD83  -/- 
mice were shown to be efficient in cytotoxic effector func- 
tion against LCMV and VSV infection. 
Discussion 
We have demonstrated in CD83  -/-  mice that thymic 
ontogeny of CD8 + T  cells is reduced but not completely 
abolished in the absence  of CD83.  This is evidenced  by a 
significant number of CD8 + T  cells remaining in the pe- 
riphery and by a normal CTL activity found in these mice 
in response  to viral infection. The thymic origin of the pe- 
ripheral CD8 + T cells in these mice is also suggested by the 
corresponding decrease in CD8o~ expression  on thymocytes 
and peripheral T cells. The result suggests that CDS~ alone 
as  a  homodimer is  inefficient for  thymic maturation  of 
CD8 § T  cells. 
It is interesting to note that CD8 § IEL in CD83  -/- 
mice is not reduced in population size or decreased in CD8o~ 
expression.  IEL are distributed at the intestinal epithelium 
and are heterogeneous populations dominated by CD8 + T 
cells with a TCR-oL/3  or y/~ (40-42). It has been suggested 
that IEL are generated extrathymically (42-45). T cells with 
autoreactive TCR are deleted in the thymus during matura- 
tion (46-51), whereas IEL with the forbidden TCR are still 
present in the intestinal epithelium (44,  45).  The observa- 
tion that IEL are not affected by the absence of CD83 in 
these mice further supports the notion that IEL are derived 
extrathymically. 
The finding of a low CD8ol expression on thymic-derived 
T cells is unexpected, because IEL do not express CDS~ and 
still retain normal levels of CD8o~ expression.  There are two 
possible explanations for this observation. It could be a con- 
sequence of preferential  thymic selection for CD8  l~  T cells. 
Alternatively, CD8 as ce/ee homodimers could be less stable 
than  oe/3  heterodimers  and  therefore  are  expressed  less 
efficiently on the cell surface. The first explanation does not 
seem to be plausible, because low CDSol expression was found 
on thymocytes at different stages of maturation. In partic- 
ular, CD8a on mature T cells is not lower than that on im- 
mature thymocytes, which argues against an enrichment for 
CD8  l~  T cells after thymic selection.  The second explana- 
tion is possible  but only applies to thymic derived T  cells, 
because the lack of CD83 has no impact on CDSo~ expres- 
sion on IEL. In fact, the specific decrease of CDSol expres- 
sion on thymic-derived T cells reveals a novel regulatory role 
of CD8B in adjusting the CDSo~ expression level on thymic- 
derived T  cells. 
We have shown in a previous report that mice heterozy- 
gous for the disrupted CDSol gene (CD8oe  +/-) have a re- 
duced cell surface expression of  both CDS~ and CD8B (50% 
of the normal level) (24).  Despite low CD8 levels, thymic 
ontogeny of CD8 +  T  cells  in  these  mice  appears  to  be 
normal (24). On the other hand, the lack of CD83 in CD83 
-/-  mice causes a similar decrease in CD8oe expression, but 
results  in  decreased  thymic ontogeny of CD8 §  T  cells. 
Thus, an overall decrease in CD8 level may not be critical, 
but complete ablation of CD83 results in impaired thymic 
ontogeny. 
How does CD83 affect the function of CD8 in thymic 
ontogeny? The role of CD83 could be quantitative in en- 
hancing the overall CD8 expression,  or qualitative in mod- 
ifying CD8 functions. In CD&x -/-  mice carrying different 
transgenic TCR,  we have  shown previously that  CD8  is 
strictly needed in positive selection, but differentially required 
in negative selection of T  cells (52).  The reduced CD8 § T 
cell population in CD83  -/-  mice could result from an 
increased negative selection, or a decreased positive selection 
of thymocytes. Further examination of CD83  -/-  mice 
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tinct role of CD8~ in positive and negative selection. 
The role of CD8B in cytotoxic function was examined by 
infecting CD8fl -/-  mice with LCMV or VSV. Cytotoxic 
T  cell activity as assessed by primary ex vivo S~Cr release 
assays was slightly less than that in wild-type control mice, 
apparently due  to  the reduced CD8 +  T  cell  population. 
After secondary in vitro stimulation with the same viral an- 
tigens, cytotoxicity  generated in CD8fl -/-  mice was efficient 
and comparable with wild-type controls. Therefore on a cell- 
to-ceU  basis  the  CD8 +  T  cells  that  lack  CD8fl  are  as 
efficient in cytotoxic function as the CD8 + T  cells in wild- 
type littermate controls. Taken together, the antigen induc- 
tion, the in vivo proliferation, the differentiation into lytic 
effector cells and the cytolytic effector function of the CD8 § 
T cells in the periphery of the CD8fl -/-  mice were shown 
to be normal. The demonstration of CTL functions against 
the above two nominal antigens in CDSfl  -/-  mice also 
suggests that the TCtk repertoire of CD8 + T cells in these 
mice is comparable with that in wild-type mice. 
The  results  obtained  from  our  CDSfl  -/-  mice  are 
different from a recent report on chimeric mice (30). We have 
provided phenotypic and functional data to suggest that a 
significant population of thymic-derived CD8 + T  cells is 
still present in CD8fl  -/-  mice. The previous report on 
chimeric mice showed only a minute CD8 § T  cell popu- 
lation in the periphery that, in contrast to our study, was 
suggested to be derived extrathymically (30).  In addition, 
the change in CD8a  expression was not reported for the 
chimeric mice. These discrepancies  probably arise from the 
limitation of the chimeric model as compared with CDSfl 
-/-  mice.  The cells to be analyzed in the chimeric mice 
represented only a fraction of the total population. Further- 
more, the population size of ES cell-derived CD8 * T cells 
could be affected by other factors,  such as competition be- 
tween defective ES cell-derived cells and normal host cells 
during thymic maturation of CD8 + T  cells. 
In summary, the phenotypic and functional studies in our 
CD8fl -/-  mice show that the absence of CD8fl only reduces 
thymic maturation of functional CD8 § T  cells. The result 
also reveals a role of CD8fl in regulating CDSol cell surface 
expression on thymic derived T cells. Despite the lack of  CDSfl 
expression,  these CD8 + T cells are functionally comparable 
to those in wild-type mice, suggesting that CD8B is not crucial 
for the antigenic response and the effector function of CD8 + 
T  cells. 
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